Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20076 - 20100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	MXI1	4601	upregulated	cupric oxide results in increased expression of MXI1 mRNA	10q25.2	A21783
Cupric oxide	Approved	MYBBP1A	10514	downregulated	cupric oxide results in decreased expression of MYBBP1A mRNA	17p13.2	A21783
Cupric oxide	Approved	MYBL1	4603	downregulated	cupric oxide results in decreased expression of MYBL1 mRNA	8q13.1	A21783
Cupric oxide	Approved	MYC	4609	downregulated	cupric oxide results in decreased expression of MYC mRNA	8q24.21	A21783
Cupric oxide	Approved	MYH9	4627	downregulated	cupric oxide results in decreased expression of MYH9 mRNA	22q12.3	A21783
Cupric oxide	Approved	MYNN	55892	upregulated	cupric oxide results in increased expression of MYNN mRNA	3q26.2	A21783
Cupric oxide	Approved	MYO1B	4430	downregulated	cupric oxide results in decreased expression of MYO1B mRNA	2q32.3	A21783
Cupric oxide	Approved	MYO5C	55930	downregulated	cupric oxide results in decreased expression of MYO5C mRNA	15q21.2	A21783
Cupric oxide	Approved	NAP1L5	266812	upregulated	cupric oxide results in increased expression of NAP1L5 mRNA	4q22.1	A21783
Cupric oxide	Approved	NCAPD2	9918	downregulated	cupric oxide results in decreased expression of NCAPD2 mRNA	12p13.31	A21783
Cupric oxide	Approved	NDC80	10403	downregulated	cupric oxide results in decreased expression of NDC80 mRNA	18p11.32	A21783
Cupric oxide	Approved	NFATC1	4772	upregulated	cupric oxide results in increased expression of NFATC1 mRNA	18q23	A21783
Cupric oxide	Approved	NFE2L3	9603	downregulated	cupric oxide results in decreased expression of NFE2L3 mRNA	7p15.2	A21783
Cupric oxide	Approved	NFIL3	4783	upregulated	cupric oxide results in increased expression of NFIL3 mRNA	9q22.31	A21783
Cupric oxide	Approved	NLK	51701	upregulated	cupric oxide results in increased expression of NLK mRNA	17q11.2	A21783
Cupric oxide	Approved	NR2F2	7026	downregulated	cupric oxide results in decreased expression of NR2F2 mRNA	15q26.2	A21783
Cupric oxide	Approved	NR4A1	3164	upregulated	cupric oxide results in increased expression of NR4A1 mRNA	12q13.13	A21783
Cupric oxide	Approved	NR4A3	8013	upregulated	cupric oxide results in increased expression of NR4A3 mRNA	9q22	A21783
Cupric oxide	Approved	NUF2	83540	downregulated	cupric oxide results in decreased expression of NUF2 mRNA	1q23.3	A21783
Cupric oxide	Approved	NUPR1	26471	upregulated	cupric oxide results in increased expression of NUPR1 mRNA	16p11.2	A21783
Cupric oxide	Approved	OBSL1	23363	downregulated	cupric oxide results in decreased expression of OBSL1 mRNA	2q35	A21783
Cupric oxide	Approved	OGT	8473	upregulated	cupric oxide results in increased expression of OGT mRNA	Xq13.1	A21783
Cupric oxide	Approved	OLFML2A	169611	downregulated	cupric oxide results in decreased expression of OLFML2A mRNA	9q33.3	A21783
Cupric oxide	Approved	OR5L2	26338	upregulated	cupric oxide results in increased expression of OR5L2 mRNA	11q12.1	A21783
Cupric oxide	Approved	OTUD4	54726	downregulated	cupric oxide results in decreased expression of OTUD4 mRNA	4q31.21	A21783

Displaying entries 20076 - 20100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability